Amphastar Pharmaceuticals Inc (AMPH)
Stock-Based Compensation
$7.09M
Quarterly · Period ending: · USD
AMPH Stock-Based Compensation
Latest reported$7.09Mperiod ending
Latest reported$7.09Mperiod ending
AMPH Quarterly Stock-Based Comp ($1.95M → $7.09M)
Quarterly stock-based compensation
High-resolution chart · PNG
AMPH stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 7,090,000 | |
| 9,274,000 | |
| 6,205,000 | |
| 6,297,000 | |
| 6,382,000 | |
| 8,393,000 | |
| 5,632,000 | |
| 5,596,000 | |
| 5,780,000 | |
| 7,360,000 | |
| 4,622,000 | |
| 4,644,000 | |
| 4,865,000 | |
| 6,111,000 | |
| 4,304,000 | |
| 4,299,000 | |
| 4,235,000 | |
| 5,022,000 | |
| 3,850,000 | |
| 3,919,000 | |
| 6,084,000 | |
| 4,834,000 | |
| 4,333,000 | |
| 4,370,000 | |
| 6,513,000 | |
| 5,282,000 | |
| 4,295,000 | |
| 4,294,000 | |
| 4,032,000 | |
| 4,674,000 | |
| 3,910,000 | |
| 3,908,000 | |
| 4,196,000 | |
| 4,666,000 | |
| 4,182,000 | |
| 4,156,000 | |
| 4,298,000 | |
| 4,451,000 | |
| 3,520,000 | |
| 3,555,000 | |
| 4,198,000 | |
| 3,851,000 | |
| 3,458,000 | |
| 3,427,000 | |
| 3,700,000 | |
| 2,230,000 | |
| 2,600,000 | |
| 2,659,000 | |
| 2,405,000 | |
| 1,616,000 | |
| 1,751,000 | |
| 2,462,000 | |
| 1,240,000 | |
| 1,582,000 | |
| 1,951,000 |